Behavioural Intervention
Nu-V3 for Chronic Pain
Greater Chicago Specialty Physicians (GCSP) - Schamuburg, Schaumburg, IL
Targeting 4 different conditionsNu-V3N/AWaitlist AvailableLed by Vipul Kella, MDResearch Sponsored by Nu-Life SolutionsEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participant presents with one or more of the following symptoms: chronic pain, anxiety, depression, and/or sleeplessness
Participant presents with one or more of the following symptoms: chronic pain, anxiety, depression, and/or sleeplessness
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up12 and 24 weeks
Awards & highlights
No Placebo-Only Group
Study Summary
This trial is testing a new device to see if it can help people with chronic pain, anxiety, depression, and/or sleeplessness.
Eligible Conditions
- Chronic Pain
- Anxiety
- Depression
- Insomnia
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowSelect...
You have ongoing issues with pain, anxiety, depression, or trouble sleeping.
Select...
You have long-lasting pain, feeling worried or sad, and trouble sleeping.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 and 24 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 and 24 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Effectiveness and overall change in reported primary symptom of concern: Anxiety
Effectiveness and overall change in reported primary symptom of concern: Chronic Pain
Effectiveness and overall change in reported primary symptom of concern: Depression
+2 moreSecondary outcome measures
Effectiveness: Symptom Frequency
Effectiveness: Symptom Severity
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Nu-V3 treatment armExperimental Treatment1 Intervention
Treatment with the Nu-V3 Device.
Group II: Observation treatment arm (SOC, control)Active Control1 Intervention
Observation following stable standard of care.
Find a site
Who is running the clinical trial?
Nu-Life SolutionsLead Sponsor
1 Previous Clinical Trials
16 Total Patients Enrolled
1 Trials studying Chronic Pain
16 Patients Enrolled for Chronic Pain
Vipul Kella, MDPrincipal Investigator
Nu-Life SolutionsEric T. Siebeneck, MSStudy Director
Nu-Life SolutionsFrequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are opportunities for patient participation in this trial still available?
"According to the information provided on clinicaltrials.gov, this specific trial is no longer recruiting participants. After first being posted in June 2022 and last edited a few days later, it has since closed its doors for recruitment but 2231 alternative trials are actively seeking hopeful candidates at present."
Answered by AI
Who else is applying?
What state do they live in?
Illinois
Wisconsin
Other
Indiana
What site did they apply to?
Greater Chicago Specialty Physicians (GCSP) - Schamuburg
EZ Clinic
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
2
0
3+
Why did patients apply to this trial?
I have tried many drugs that didn’t help. Pain issues not helped with other medications.
Patient
I discovered this clinical trial while researching alternative (non pharmaceutical) methods of treating anxiety and depression.
Patient
I was diagnosed with Fibromyalgia in 2019, after dealing with unexplained chronic pain for 2yrs already. Trying to find other methods and treatments to manage the pain levels.
Patient
I have been on prozak, Zoloft, celexa (which this medicine gave me hives inside my body from being allergic, had to get benadryl shot). I hate taking pills I would love to find a option that would be possible to be pill free thank you for your consideration!
Patient
What questions have other patients asked about this trial?
I am currently active in counseling and am taking 40/mg of fluoxetine and 60/mg of propranolol daily... would these medications prevent me from eligibility?
Patient